Immune response of COVID-19 vaccinated liver transplant patients is less robust compared to healthy patients (IMAGE)

Elsevier

Immune response of COVID-19 vaccinated liver transplant patients is less robust compared to healthy patients

Caption

For liver transplant patients who had never been infected with COVID-19, taking a higher daily dose of the immunosuppressive drug mycophenolate mofetil reduced the effectiveness of the anti-SARS-CoV-2 mRNA Pfizer-BioNTech vaccine.

Credit

Journal of Hepatology

Usage Restrictions

Please include attribution

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.